CARDIAC MORPHOLOGY AND LEFT-VENTRICULAR FUNCTION IN NORMOTENSIVE MORBIDLY OBESE PATIENTS WITH AND WITHOUT CONGESTIVE-HEART-FAILURE, AND EFFECT OF WEIGHT-LOSS
Ma. Alpert et al., CARDIAC MORPHOLOGY AND LEFT-VENTRICULAR FUNCTION IN NORMOTENSIVE MORBIDLY OBESE PATIENTS WITH AND WITHOUT CONGESTIVE-HEART-FAILURE, AND EFFECT OF WEIGHT-LOSS, The American journal of cardiology, 80(6), 1997, pp. 736-740
To assess cardiac morphology and left ventricular (LV) function in nor
motensive morbidly obese patients with and without congestive heart fa
ilure (CHF) we performed a physical examination and obtained a transth
oracic echocardiogram and cardiac Doppler studies before and after sub
stantial weight loss in patients whose actual body weight was initiall
y equal to or more than twice their ideal body weight and who were fre
e from systemic hypertension and underlying organic heart disease. The
re were 24 patients with CHF, 14 of whom were studied after weight los
s. There were 50 patients without CHF, 39 of whom were studied after w
eight loss. Compared to patients without CHF, those with CHF had signi
ficantly greater mean LV internal dimension in diastole, LV end-systol
ic wall stress, LV mass/height index values, left atrial dimension and
right ventricular internal dimension values, significantly lower mean
LV fractional shortening, and transmitral Doppler E/A ratio values, a
nd significantly longer mean transmitral E-wave deceleration time and
duration of morbid obesity than patients without CHF. Substantial weig
ht loss in those with and without CHF produced comparable reductions i
n mean LV internal dimension in diastole, LV end-systolic wall stress,
LV mass/height index, transmitral Doppler E-wave deceleration time, a
nd left atrial dimension, and comparable increases in LV fractional sh
ortening and transmitral Doppler E/A ratio. Linear regression analysis
identified duration of morbid obesity as the strongest predictor of C
HF (p <0.00000002). Thus, LV mass is greater and LV systolic function
and diastolic filling are more impaired in normotensive morbidly obese
subjects with CHF than in those without CHF. Duration of morbid obesi
ty is the strongest predictor of CHF among the variables studied. Subs
tantial weight loss produces comparable changes in cardiac morphology
and function in those with and without CHF. (C) 1997 by Excerpta Medic
a, Inc.